Call Now

Chronic Pulmonary Hypoxic Ischemic Heart Disease (CHHD)

Chronic anoxic heart disease; Chronic Hypoxic Heart Disease; Chronic Obstructive Pulmonary Disease

Chronic pulmonary heart disease usually results in right ventricular hypertrophy (RVH), whereas acute pulmonary heart disease usually results in dilatation. Hypertrophy is an adaptive response to a long-term increase in pressure. Individual muscle cells grow larger (in thickness) and change to drive the increased contractile force required to move the blood against greater resistance. Dilatation is a stretching (in length) of the ventricle in response to acute increased pressure. To be classified as pulmonary heart disease, the cause must originate in the pulmonary circulation system. Two causes are vascular changes as a result of tissue damag), and chronic hypoxic pulmonary vasoconstriction.


Organism species: Pan-species (General)

PRODUCT TYPE CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins N/A Recombinant Chronic Pulmonary Hypoxic Ischemic Heart Disease (CHHD) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Chronic Pulmonary Hypoxic Ischemic Heart Disease (CHHD) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Chronic Pulmonary Hypoxic Ischemic Heart Disease (CHHD) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Chronic Pulmonary Hypoxic Ischemic Heart Disease (CHHD) CLIA Kit Customized Service Offer
N/A ELISA Kit for Chronic Pulmonary Hypoxic Ischemic Heart Disease (CHHD) ELISA Kit Customized Service Offer